(Q35826428)

English

Pharmacokinetic/pharmacodynamic models for the depletion of Vbeta5.2/5.3 T cells by the monoclonal antibody ATM-027 in patients with multiple sclerosis, as measured by FACS

scientific article published in October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

Pharmacokinetic/pharmacodynamic models for the depletion of Vbeta5.2/5.3 T cells by the monoclonal antibody ATM-027 in patients with multiple sclerosis, as measured by FACS (English)

1 reference

Europe PubMed Central

10 August 2017

monoclonal antibody

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

Mats O Karlsson

3

object named as

Mats O Karlsson

1 reference

Europe PubMed Central

10 August 2017

author name string

Per-Henrik Zingmark

1

1 reference

Europe PubMed Central

10 August 2017

Charlotte Edenius

2

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

1 October 2004

1 reference

Europe PubMed Central

10 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

10 August 2017

58

1 reference

Europe PubMed Central

10 August 2017

4

1 reference

Europe PubMed Central

10 August 2017

378-389

1 reference

Europe PubMed Central

10 August 2017

Pharmacokinetic/pharmacodynamic model for prednisolone inhibition of whole blood lymphocyte proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884610

27 July 2018

Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884610

27 July 2018

A population pharmacokinetic-pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884610

27 July 2018

A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884610

27 July 2018

Autoimmunity to collagen II and myelin basic protein: comparative studies in humans and rodents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884610

27 July 2018

Depot characteristics and biodistribution of interleukin-2 liposomes: importance of route of administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884610

27 July 2018

Immunological aspects of demyelinating diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884610

27 July 2018

Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884610

27 July 2018

Antibody-mediated suppression of Vbeta5.2/5.3(+) T cells in multiple sclerosis: results from an MRI-monitored phase II clinical trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02177.X

21 January 2018

Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02177.X

21 January 2018

Immunomodulatory and hematopoietic effects of recombinant human interleukin-6 in patients with advanced renal cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15373930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

1 reference

https://pubmed.ncbi.nlm.nih.gov/15373930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics and pharmacodynamics of the anti-CD11a antibody hu1124 in human subjects with psoriasis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15373930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A population pharmacokinetic screen to identify demographic-clinical covariates of basiliximab in liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15373930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depletion of Vbeta5.2/5.3 T cells with a humanized antibody in patients with multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15373930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.2004.02177.X

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35826428&oldid=2143946784"